These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 19897178)

  • 1. Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs.
    Andreasen NC; Pressler M; Nopoulos P; Miller D; Ho BC
    Biol Psychiatry; 2010 Feb; 67(3):255-62. PubMed ID: 19897178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlorpromazine equivalent doses for the newer atypical antipsychotics.
    Woods SW
    J Clin Psychiatry; 2003 Jun; 64(6):663-7. PubMed ID: 12823080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlorpromazine equivalents versus defined daily doses: how to compare antipsychotic drug doses?
    Rijcken CA; Monster TB; Brouwers JR; de Jong-van den Berg LT
    J Clin Psychopharmacol; 2003 Dec; 23(6):657-9. PubMed ID: 14624195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
    Yıldız M; Osman E
    Turk Psikiyatri Derg; 2022; 33(2):146-148. PubMed ID: 35730516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
    Tada M; Shirakawa K; Matsuoka N; Mutoh S
    Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of drug responses in schizophrenia: a method using a test dose of chlorpromazine.
    Minami H; Nakahara T; Miyahara A; Nakane Y
    Psychiatry Clin Neurosci; 1997 Aug; 51(4):217-22. PubMed ID: 9316167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic drugs in breast-milk: a study of pharmacokinetics and of possible adverse effects in breast-fed infants.
    Yoshida K; Smith B; Craggs M; Kumar R
    Psychol Med; 1998 Jan; 28(1):81-91. PubMed ID: 9483685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of the cytochrome P450 2D6 genotype for the drug metabolic interaction between chlorpromazine and haloperidol.
    Suzuki Y; Someya T; Shimoda K; Hirokane G; Morita S; Yokono A; Inoue Y; Takahashi S
    Ther Drug Monit; 2001 Aug; 23(4):363-8. PubMed ID: 11477317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haloperidol versus chlorpromazine for schizophrenia.
    Leucht C; Kitzmantel M; Chua L; Kane J; Leucht S
    Cochrane Database Syst Rev; 2008 Jan; (1):CD004278. PubMed ID: 18254045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical application of the concept of relative potency: an example involving chlorpromazine and haloperidol.
    Preskorn SH
    J Psychiatr Pract; 2005 Jul; 11(4):258-61. PubMed ID: 16041236
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of d-limonene, alpha-pinene and cineole on in vitro transdermal human skin penetration of chlorpromazine and haloperidol.
    Almirall M; Montaña J; Escribano E; Obach R; Berrozpe JD
    Arzneimittelforschung; 1996 Jul; 46(7):676-80. PubMed ID: 8842336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the anti-dopamine D₂ and anti-serotonin 5-HT(2A) activities of chlorpromazine, bromperidol, haloperidol and second-generation antipsychotics parent compounds and metabolites thereof.
    Suzuki H; Gen K; Inoue Y
    J Psychopharmacol; 2013 Apr; 27(4):396-400. PubMed ID: 23427194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma level monitoring of antipsychotic drugs. Clinical utility.
    Dahl SG
    Clin Pharmacokinet; 1986; 11(1):36-61. PubMed ID: 2868820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol.
    Tollefson GD; Beasley CM; Tamura RN; Tran PV; Potvin JH
    Am J Psychiatry; 1997 Sep; 154(9):1248-54. PubMed ID: 9286184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extract of Synedrella nodiflora (L) Gaertn exhibits antipsychotic properties in murine models of psychosis.
    Amoateng P; Adjei S; Osei-Safo D; Kukuia KKE; Bekoe EO; Karikari TK; Kombian SB
    BMC Complement Altern Med; 2017 Aug; 17(1):389. PubMed ID: 28784133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of phenothiazine and butyrophenone antipsychotic drugs. A review of some recent research findings and clinical implications.
    Hubbard JW; Midha KK; Hawes EM; McKay G; Marder SR; Aravagiri M; Korchinski ED
    Br J Psychiatry Suppl; 1993 Dec; (22):19-24. PubMed ID: 7906521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of antipsychotic drugs to cortical 5-HT2A receptors: a PET study of chlorpromazine, clozapine, and amisulpride in schizophrenic patients.
    Trichard C; Paillère-Martinot ML; Attar-Levy D; Recassens C; Monnet F; Martinot JL
    Am J Psychiatry; 1998 Apr; 155(4):505-8. PubMed ID: 9545996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia.
    Reschke RW
    Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug therapy for delirium in terminally ill adults.
    Finucane AM; Jones L; Leurent B; Sampson EL; Stone P; Tookman A; Candy B
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD004770. PubMed ID: 31960954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders.
    Dold M; Samara MT; Li C; Tardy M; Leucht S
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD009831. PubMed ID: 25592299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.